A detailed history of Krs Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Krs Capital Management, LLC holds 8,328 shares of ABBV stock, worth $1.5 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
8,328
Previous 8,781 5.16%
Holding current value
$1.5 Million
Previous $1.51 Million 9.16%
% of portfolio
1.2%
Previous 1.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $74,219 - $90,296
-453 Reduced 5.16%
8,328 $1.64 Million
Q2 2024

Jul 17, 2024

SELL
$154.79 - $180.76 $34,518 - $40,309
-223 Reduced 2.48%
8,781 $1.51 Million
Q1 2024

Apr 16, 2024

SELL
$159.82 - $182.1 $110,275 - $125,649
-690 Reduced 7.12%
9,004 $1.64 Million
Q4 2023

Jan 24, 2024

SELL
$137.6 - $154.97 $35,776 - $40,292
-260 Reduced 2.61%
9,694 $1.5 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $37,939 - $43,920
284 Added 2.94%
9,954 $1.48 Million
Q2 2023

Jul 14, 2023

BUY
$132.51 - $164.9 $3,312 - $4,122
25 Added 0.26%
9,670 $1.3 Million
Q1 2023

Apr 11, 2023

BUY
$144.61 - $166.54 $10,701 - $12,323
74 Added 0.77%
9,645 $1.54 Million
Q4 2022

Jan 19, 2023

BUY
$138.31 - $165.87 $3,319 - $3,980
24 Added 0.25%
9,571 $0
Q3 2022

Oct 21, 2022

BUY
$134.21 - $153.93 $6,307 - $7,234
47 Added 0.49%
9,547 $1.28 Million
Q2 2022

Aug 02, 2022

SELL
$137.62 - $174.96 $3,578 - $4,548
-26 Reduced 0.27%
9,500 $1.46 Million
Q1 2022

Apr 27, 2022

BUY
$131.98 - $163.75 $2,903 - $3,602
22 Added 0.23%
9,526 $1.54 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $1.02 Million - $1.29 Million
9,504 New
9,504 $1.29 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Krs Capital Management, LLC Portfolio

Follow Krs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krs Capital Management, LLC with notifications on news.